Abstract
Beckwith-Wiedemann syndrome (BWS) is characterized by numerous growth abnormalities and an increased risk of childhood tumors. The gene for BWS is localized in the 11p15.5 region, as determined by linkage analysis of autosomal dominant pedigrees. The increased maternal transmission pattern seen in the autosomal dominant-type pedigrees and the findings of paternal uniparental disomy reported for a subgroup of patients indicate that the gene for BWS is imprinted. Previously, we found p57KIP2, which is a Cdk-kinase inhibitor located at 11p15, is mutated in two BWS patients. Here, we screened for the mutation of the gene in 15 BWS patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 25 March 1997 / Accepted: 22 May 1997
Rights and permissions
About this article
Cite this article
Hatada, I., Nabetani, A., Morisaki, H. et al. New p57KIP2 mutations in Beckwith-Wiedemann syndrome. Hum Genet 100, 681–683 (1997). https://doi.org/10.1007/s004390050573
Issue Date:
DOI: https://doi.org/10.1007/s004390050573